Category: Regulatory DisclosuresBy adminSeptember 5, 2022 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:EGX disclosure regarding the upcoming OGM on 29 September 2022NextNext post:Disclosure to EGX on Treasury SharesRelated PostsRameda Announces New Chairman and Additions to its Board of DirectorsJune 3, 2026Rameda Initiates First Acquisition of 2025July 7, 2025Record Dividend Distribution DisclosureJuly 7, 2025BOD-Shareholding-Structure-2024April 15, 2024The invitation to shareholders for the AGMMarch 31, 2024RetractionMarch 24, 2024
